ARTICLE | Company News
MediGene and Aventis cancer deal
February 16, 2000 8:00 AM UTC
Aventis (AVE; NM:AVE; DAX:AVE) received an exclusive license to develop and commercialize MediGene's vaccine to treat malignant melanoma in 37 countries, including the European Union, U.S., Japan and ...